InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Blasticidin | Developing synthetic tools to decipher the tumor-immune interactome. | 2023 | PNAS | Weizman O.E. et al. | DOI: 10.1073/pnas.2306632120 |
G418 (Geneticin) | Developing synthetic tools to decipher the tumor-immune interactome. | 2023 | PNAS | Weizman O.E. et al. | DOI: 10.1073/pnas.2306632120 |
Puromycin | Developing synthetic tools to decipher the tumor-immune interactome. | 2023 | PNAS | Weizman O.E. et al. | DOI: 10.1073/pnas.2306632120 |
LyoVec™ | The parapoxvirus Orf virus inhibits dsDNA-mediated type I IFN expression via ... | 2023 | J Gen Virol. | AlDaif B.A. et al. | DOI: 10.1099/jgv.0.001912 |
Primocin® | Organoids transplantation attenuates intestinal ischemia/reperfusion injury i... | 2023 | Nat Commun. | Zhang F.L. et al. | DOI: 10.1038/s41467-023-42502-0 |
EndoFit Ovalbumin | Immune synapse formation promotes lipid peroxidation and MHC-I upregulation i... | 2023 | Nat Commun. | Calzada-Fraile D. et al. | DOI: 10.1038/s41467-023-42480-3 |
Human ACE2 & TMPRSS2 expressing A549 Cells | An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection... | 2023 | Nat Commun. | Yuen C.K. et al. | DOI: 10.1038/s41467-023-42349-5 |
LPS-EB VacciGrade™ | Protocol for cytokine and uterine immune cell characterization in a mouse mod... | 2023 | STAR Protoc. | Wayland J.L. et al. | DOI: 10.1016/j.xpro.2023.102643 |
Primocin® | Sympathetic activity regulates epithelial proliferation and wound healing via... | 2023 | Sci Rep. | Ten Hove A.S. et al. | DOI: 10.1038/s41598-023-45160-w |
LPS-EK (LPS from E. coli K12) | Immune Activation Profiles Elicited by Distinct, Repeated TLR Agonist Infusio... | 2023 | J Immunol. | King H.A.D. et al. | DOI: 10.4049/jimmunol.2300424 |
Poly(I:C) LMW | Immunogenicity of rabies virus G mRNA formulated with lipid nanoparticles and... | 2023 | Vaccine | Hongtu Q. et al. | DOI: 10.1016/j.vaccine.2023.10.019 |
LPS-EB (LPS from E. coli O111:B4) | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
L18-MDP | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
R848 (Resiquimod) | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
2'3'-cGAMP | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
ssRNA40/LyoVec™ | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
C12-iE-DAP | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
Poly(I:C) HMW | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
THP1-Dual™ Cells | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
QUANTI-Blue™ | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |